6 results
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... Individualized Treatment ... p-Aminosalicylic acid, High-dose ... Tuberculosis #MDRTB #management ... #regimens #pharmacology
Malignant Hyperthermia is a very rare, but life-threatening condition that can occur after using certain anesthetic
volatile anesthetic drugs ... When it does occur ... #management #treatment ... #algorithm ... Therapeutics and Clinical
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
& Dry) is the treatment ... adjusting the dose ... #algorithm #management ... #table #foamed ... #pharmacology
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
months or • RFB (dose ... and molecular diagnostic ... HIV-infected persons with clinical ... Please refer to the table ... #management #opportunistic
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
contralateral eye ... injection) for 1–4 doses ... intraocular levels of drug ... #management #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
disease based on clinical ... please refer to Table ... #Prevention #Treatment ... #management #opportunistic ... infections #HIVAIDS #pharmacology